Yousef Zakharia is the first person who told me - as a first year Internal Medicine resident Internal Medicine at Iowa - that I should consider Oncology. I emailed him 6 weeks later to see if he would be my research mentor 🥹 We may be colleagues now but I still look up to him!

Thrilled to lead AI in Healthcare session at Mayo Clinic &Illinois Alliance computational genomics course. We have outstanding speakers, Ken Kehl Dana-Farber Division of Population Sciences, YooJung Choi, ASU, and a lab by supertalented Syed Arsalan Ahmed Naqvi, Umair Ayub, Mihir Parmar. 🔗 rb.gy/tlnl8u

Best of ASCO@ Milwaukee Binaytara Foundation

Ending day 1 of #BestofASCO24 📍Milwaukee with a Genitourinary Cancer session ft. Christos Kyriakopoulos (University of Wisconsin Department of Medicine), Yousef Zakharia (University of Iowa Health Care), and Benjamin L Maughan (Huntsman Cancer Institute).

Meet the incredible Abstract Committee! These dedicated experts have carefully selected the abstracts for #KCRS24. Huge thanks to this amazing group! Sumanta K. Pal, MD, FASCO Rana McKay, MD, FASCO Yu-Wei Chen, MD, MS Alex Chehrazi-Raffle, MD Scott Haake, MD, PhD Yousef Zakharia Evita Sadimin #KidneyCancer #AcceleratingCures

1/5 Excited to share our @MsaouelLab clinical analysis of 135 patients with #RenalMedullaryCarcinoma treated MD Anderson Cancer Center over 20 years 👉sciencedirect.com/science/articl… #endRMC #rarecancers Kidney Cancer Chris Johnson Foundation Inc. RMC Alliance R.M.C. Inc Rare Cancer Research Foundation + Pattern.org The Renal Medullary Carcinoma Research Foundation KCCure

In this interview, Yousef Zakharia of UI Holden Comprehensive Cancer Center is interviewed about a Big Ten CRC phase 1/2 trial combining durvalumab and guadecitabine in metastatic kidney cancer. Read more here: urotoday.com/video-lectures…

Can’t miss! The The Oncologist #KCRS24 abstract supplement is out! 🔗 bit.ly/KCRS24Abstract #KidneyCancer #RCC #AcceleratingCures OncoAlert Toni Choueiri, MD Hans Hammers Sumanta K. Pal, MD, FASCO Rana McKay, MD, FASCO ari hakimi Yüksel Ürün

Selected for my first oral presentation at a conference and couldn’t be more grateful it’s at #ASCOQLTY24. Looking forward to sharing our findings in disparities in mental health screening for women Veterans with breast cancer. #bc Veterans Affairs University of Iowa Health Care Internal Medicine at Iowa

✨✨SUBMISSION DEADLINE EXTENDED✨✨ Abstract submissions for #IKCSNA24 now accepted through **Sept 3** Submit: 🧡LBAs 🧡Original research (complete or in-progress) 🧡Encore abstracts 🧡Case reports 🧡And more! Guidelines at the submission portal: kidneycancer.swoogo.com/IKCSNA24/cfs/5…

Abstracts extended! Submit here kidneycancer.swoogo.com/IKCSNA24/cfs/5… This is an amazing meeting and hope to see the Kidney Cancer Community in Louisville in Nov! Yousef Zakharia Sarah P. Psutka MD MS Qing Zhang Tian Zhang, MD, MHS Phillip Pierorazio Brian Rini, MD #IKCSNA24

Deadline Extended!!! 🚨 Abstract submissions for #IKCSNA24 are now being accepted through 9/3! Join Salvatore La Rosa, our Chief Scientific Officer, as he shares why this is a can't-miss opportunity for the #kidneycancer research community: bit.ly/4dw1ifS

22 yrs ago, purchased my 1st English medical textbook with English-Arabic dictionary as we studied medicine in Arabic 20 yrs ago, my 1st trip to US to improve my English Today Professor of Medicine! Many ups and downs in between, let alone visa issues What a Journey! V Thankful

Durvalumab + guadecitabine in metastatic #KidneyCancer. Yousef Zakharia UI Holden Comprehensive Cancer Center discusses phase 1/2 results with Pedro C Barata, MD MSc FACP Case Comp Cancer Ctr and highlights the potential for further research, including the possibility of a triplet combination with IO/TKI > bit.ly/47az1cm

My second book “THE CANCER JOURNEY” launches 9/24/24 & is available to pre-order a.co/d/f0mwZCZ I leverage storytelling to explain & simplify everything related to cancer from A-Z; written in an easy to read & understand language so it reaches everyone. Check it out.

I am delighted to share our manuscript evaluating Tumor Mutational Burden (TMB) and Microsatellite Instability (MSI) in pts with #Urothelialcancer treated with ICIs Thanks to our amazing team Petros Grivas Ali Khaki Rafee Talukder University of Washington Fred Hutchinson Cancer Center sciencedirect.com/science/articl… (1/7)

Just in Journal of Clinical Oncology 👉Final OS analysis of SWOG Cancer Research Network 1500 trial 👉 data support cabozantinib for treatment of advanced papillary RCC #kidneycancer (unless clinical trials are available). Free access paper 👉 tinyurl.com/2s3t7z27 Congrats Pedro C Barata, MD MSc FACP & Sumanta K. Pal, MD, FASCO & authors Naomi Haas

What a terrific crew! The future of #oncology gathered at #ESMO24.